Emily Curran

Hematologist with focus on leukemia, MDS and AYA Oncology. Opinions ≠ my employers' nor med advice. Follows & RTs ≠ endorsements.

[Emily Curran @ECurranMD]

Honored to have been a part of this amazing meeting. Sincere thanks to the Turkish Society of Hematology and ASH for organizing. Was wonderful to see old friends and meet new colleagues! @NitinJainMD @kristenpettitmd

[A. Emre Eşkazan, MD 🩸�� @eskazanae]

@CemreSucubulak @adsouza_md thank you so much!
and also many thanks to all experts coming for the ASH Highlights in the Mediterranean including @NitinJainMD @myeloidmalig @kristenpettitmd @Geoff_Uy @ECurranMD @DrLaCasce @DrMonzrAlMalki @SwapnaThota and more 🙏
@ASH_hematology
➡️https://t.co/fZEmdmEEea

[A. Emre Eşkazan, MD 🩸🔬 @eskazanae]

@CemreSucubulak @adsouza_md thank you so much!
and also many thanks to all experts coming for the ASH Highlights in the Mediterranean including @NitinJainMD @myeloidmalig @kristenpettitmd @Geoff_Uy @ECurranMD @DrLaCasce @DrMonzrAlMalki @SwapnaThota and more 🙏
@ASH_hematology
➡️https://t.co/fZEmdmEEea

[Marlise R. Luskin MD, MSCE @LuskinMarlise]

We look forward to welcoming our first Foley Family Fellow in Leukemia in one year! Apply to the
https://t.co/MEt0Y4A4sM by Aug 15. @DanaFarber.

[Lori Muffly @LoriMuffly]

@LuskinMarlise @ECurranMD nothing makes me happier than the opportunity to speak alongside both of you!

[Decera Clinical Education @DeceraClinEdu]

@ECurranMD + @KSchmiegelow are presenting new approaches to optimize #asparaginase therapy in the mgmt of #acute #lymphoblastic #leukemia Sunday morning June 5 in Chicago and virtually online #ASCO22 💻 Register for free➡️https://t.co/ThXmsOxcfT

[Emily Curran @ECurranMD]

Best part of ASH is always seeing old friends! Such a wonderful and inspiring group of people. Can’t wait until next year!

[Anand Patel @Anand_88_Patel]

#ASH21 the Dr. Stock @myeloidmalig @SoniSmithMD mentee crew (missing many!) @ECurranMD @LoriMuffly @CanerSaygin @AfafOsman7

[Blood Advances @BloodAdvances]

Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia https://t.co/eX0B9e4cOx #ALL #leusm

[Bhavana (Tina) Bhatnagar @tinabhatnagar01]

@FertilityNP Thanks for mentioning @BradZebrack and @DrAnneKatz as speakers for the NCH/OSU AYA Symposium! Adding @DrLeslieAppiah @SarahSeeAYA @BLockwoodMD @ECurranMD @KarenMoody @mroth_MD, Mitch Cairo and Sam Hulett to round out our amazing speaker lineup! #pedsmedchat #ayascm

[Syed A. Ahmad @SyedAAhmad5]

This is a worrisome trend. Cancer incidents in young adults increasing. Trends in Cancer Incidence in US Adolescents and Young Adults, 1973-2015 https://t.co/Zyt4G6Q44O

[ASH Clinical News @ASHClinicalNews]

We spoke with Wendy Stock, 2020 @ASH_hematology Mentor Award recipient for clinical medicine, about the joy of cultivating the next generation of clinicians and researchers #ASH20 https://t.co/5NkMSmb3gh

[Emily Curran @ECurranMD]

Such an inspiration to so many mentees, especially female hematologists. She is an amazing scientist, physician, mother, and friend - showing us all that this can be possible. So honored to be a part of the “Wendy Stock fan club” #ASHKudos #SHEmatology @HemOncWomenDocs

[ASH @ASH_hematology]

Wendy Stock, MD, of @UChicago, with the 2020 ASH Mentor Award for contributing to the professional development of #hematology trainees at various stages in their careers.

Say #ASHKudos and watch her entire speech on the #ASH20 platform.

[Anand Patel @Anand_88_Patel]

Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults | NEJM https://t.co/aqVUluscJA

[Syed A. Ahmad @SyedAAhmad5]

Congrats to our own @UCHealthNews, @TMWiseDraper for being high lighted by @OncJournal @DavendraSohal @kharofaJ @UCResearch

[Emily Curran @ECurranMD]

Check out this great resource on acute leukemias, including our perspective on Ph-like ALL!

[Benlazar S M A @smbenlazar]

A new release by Springer: Acute leukemia #leusm

[Emily Curran @ECurranMD]

So excited to open this trial at @uc_health

[PrECOG @PrECOGonc]

.@uc_health in Cincinnati is now enrolling patients with acute myeloid #leukemia (#AML) w/ a FLT3 mutation in clinical trial PrE0905. Learn more: https://t.co/6Zx1NaiANq #leusm cc: @ECurranMD

[University of Chicago Hem/Onc Fellows @UCHemOncFellows]

Throwback to an article by @AmyWangDuncanMD with mentorship from the leukemia and trasnsplant faculty at @UCCancerCenter looking at toxicities of nivolumab after allo-transplant!

https://t.co/NOQlncHzUn

[Inas Abuali, MD @inas_md]

I felt a lot of #ImposterSyndrome writing my Oct @ASCO Connection column! But it was about my journey so far as a #ClinicianEducator and where I hope to go from here. Here are some tips that I wanted to share. Please share yours #MedTwitter!
https://t.co/HwzQtdLglb

[Ben Derman @bdermanmd]

His legacy looms large - trained hundreds if not thousands of housestaff. Just the other day, a patient reminisced how Dr. Baron diagnosed him when nobody else could. A master diagnostician and one of the kindest and warmest people I knew. May his memory be a blessing.

[Inas Abuali, MD @inas_md]

My latest #ASCODailyNews article on the persistent #disparities in #cancercare, current challenges and emerging strategies. Much work remains to ensure #equity.
@ASCO @ASCO_pubs @ASCOPres @uc_health #MedTwitter #AcademicTwitter #ASCO20
1/
https://t.co/7BHOhUvk40

[University of Cincinnati HemOnc Fellowship @Cincyhemonc]

We love to see our faculty like @TMWiseDraper making the @ASCO Evening Post. New findings about cancer treatment and COVID-19. Read about it here. #UCResearch

https://t.co/NcTTKMxBW2